Details about COVID-19, monkeypox, and the flu vaccine
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Single Session Class to Reduce Opioid Use in Chronic Pain
Trial ID or NCT#
Status
Purpose
Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.
Official Title
Single Session Pain Catastrophizing Class: Efficacy & Mechanisms for Reducing Opioid Use Among Chronic Pain Patients
Eligibility Criteria
- - 18-80 years of age - Diagnosis of chronic non-cancer pain (> 3 months in duration) - Currently using prescription opioids ≥ 20mg morphine equivalent daily dose (MEDD) for ≥ 3 months; - Ability and willingness to complete study procedures.
- - Open litigation regarding a medical condition - Inability to provide informed consent and complete study procedures - Active suicidality.
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Maisa Ziadni
(313) 725-0615
View on ClinicalTrials.gov
About this Clinical Trial
Single Session Class to Reduce Opioid Use in Chronic Pain
Your Message Will Go To
Maisa Ziadni313-725-0615